Glass Jacobson Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.05K	Hold	208	–	–	﹤0.01%	492
2026 Q1	$6.26K	Hold	208	–	–	﹤0.01%	490
2025 Q4	$6.49K	Sell	208 -353	-63%	-$8.7K	﹤0.01%	478
2025 Q3	$11.3K	Hold	561	–	–	﹤0.01%	442
2025 Q2	$9.4K	Hold	561	–	–	﹤0.01%	432
2025 Q1	$12.4K	Hold	561	–	–	﹤0.01%	577
2024 Q4	$12.4K	Sell	561 -50	-8%	-$910	﹤0.01%	577
2024 Q3	$11K	Sell	611 -30	-5%	-$525	﹤0.01%	554
2024 Q2	$10.4K	Sell	641 -114	-15%	-$1.76K	﹤0.01%	545
2024 Q1	$10.7K	Buy	755 +589	+355%	+$7.42K	﹤0.01%	547
2023 Q4	$1.73K	Hold	166	–	–	﹤0.01%	658
2023 Q3	$1.69K	Sell	166 -1,000	-86%	-$9.31K	﹤0.01%	648
2023 Q2	$8.78K	Buy	+1,166	New	+$9.46K	﹤0.01%	519
2022 Q4	$10.6K	Buy	+1,166	New	+$10.2K	0.01%	511

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Glass Jacobson Investment Advisors's TEVA Position: Q2 2026 in Review

Glass Jacobson Investment Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 208 shares worth $7.05K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Glass Jacobson Investment Advisors first reported a position in TEVA in Q4 2022 and has held it in 14 quarters since. The position peaked at $12.4K in Q1 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Glass Jacobson Investment Advisors held 208 shares of Teva Pharmaceuticals worth $7.05K as of Q2 2026.
Glass Jacobson Investment Advisors left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Glass Jacobson Investment Advisors's portfolio in Q2 2026, its #492 holding.
Glass Jacobson Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2022 and has held it in 14 quarters since.
Glass Jacobson Investment Advisors's Teva Pharmaceuticals position peaked at $12.4K in Q1 2025.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Glass Jacobson Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.